A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation

NCT05379829 ·Status: COMPLETED ·Phase: PHASE1

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

NCT07289763 ·Status: RECRUITING ·Phase: PHASE2

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 ·Status: TERMINATED ·Phase: PHASE2

A Trial of HRS-5965 Tablets in Primary IgA Nephropathy

NCT06137768 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy

NCT07135219 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

NCT05534919 ·Status: COMPLETED ·Phase: PHASE3

The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.

NCT03466801 ·Status: TERMINATED ·Phase: NA

Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China

NCT01596855 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis

NCT02063100 ·Status: UNKNOWN ·Phase: PHASE4

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

NCT04154670 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy

NCT06573411 ·Status: RECRUITING ·Phase: PHASE4

Study of FG-4592 in Subjects With Chronic Kidney Disease in China

NCT01599507 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461 ·Status: COMPLETED ·Phase: PHASE2

Obinutuzumab in the Management of Idiopathic Membranous Nephropathy

NCT05845762 ·Status: UNKNOWN

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

NCT04776187 ·Status: UNKNOWN ·Phase: PHASE4

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

NCT05514015 ·Status: RECRUITING ·Phase: PHASE4

A Study of Telitacicept for IgA Nephropathy (TELIGAN)

NCT05799287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

NCT04939116 ·Status: UNKNOWN ·Phase: PHASE2

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

NCT05668403 ·Status: RECRUITING ·Phase: PHASE1

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

NCT02384317 ·Status: COMPLETED ·Phase: PHASE2

Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy

NCT02662283 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

NCT00956059 ·Status: UNKNOWN ·Phase: NA

Different Immunosuppressive Treatment in iMN

NCT04745728 ·Status: RECRUITING ·Phase: PHASE3